¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23
±³À°ÀÏÀÚ : 2024-06-23
±³À°Àå¼Ò : ¼­¿ïµå·¡°ï½ÃƼȣÅÚ ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ

±³À°ÁÖÁ¦ : ´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇѵÎÅëÇÐȸ
´ã´çÀÚ : ±èÀ¯Áø
¿¬¶ôó : 02-974-8606   

À̸ÞÀÏ : kheadache2014@gmail.com

±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, ½Å°æ¿Ü°ú, À̺ñÀÎÈÄ°ú, ½Å°æ°ú, °¡Á¤ÀÇÇаú, ÀÀ±ÞÀÇÇаú, ÀÇ»çÇÐ, ÀÇÇб³À°

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 46ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í <»çÀüµî·Ï>Æò»ýȸ¿ø¹×2024¿¬È¸ºñ³³ºÎÁ¤È¸¿ø40,000¿ø,¹Ì³³Á¤È¸¿ø70,000¿ø,ÁØȸ¿ø Àü°øÀÇ ¹«·á, ÁØȸ¿ø(±âŸȸ¿ø,±ºÀÇ°ü,°øº¸ÀÇ)40,000¿ø,ºñȸ¿ø70,000¿ø <ÇöÀåµî·Ï>Æò»ýȸ¿ø¹×2024¿¬È¸ºñ³³ºÎÁ¤È¸¿ø50,000¿ø,¹Ì³³Á¤È¸¿ø80,000¿ø,ÁØȸ¿ø Àü°øÀÇ ¹«·á, ÁØȸ¿ø(±âŸȸ¿ø,±ºÀÇ°ü,°øº¸ÀÇ)50,000¿ø,ºñȸ¿ø80,000¿ø <¿öÅ©¼¥> 40,000¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:10~09:30 Genetics in Migraine and Cluster (ÆíµÎÅë°ú ±º¹ßµÎÅëÀÇ À¯ÀüÇÐ) ±èÁØÈ£(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:30~09:50 Glymphatic System and Migraine (ÆíµÎÅë¿¡¼­ ±Û¸²ÆÄƽ½ºÀÇ ¿ªÇÒ) ¹Ú°­¹Î(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 09:50~10:10 Pharmacological and Non-Pharmacological Treatment in Pediatric Migraine (¼Ò¾ÆÆíµÎÅë¿¡¼­ ¾à¹° ¹× ºñ¾à¹°Ä¡·á) º¯¼ºÈ¯(ºÐ´çÁ¦»ýº´¿ø)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:10~10:30 Neuromodulation in Migriane and Cluster (ÆíµÎÅë °ú ±º¹ßµÎÅë¿¡¼­ ½Å°æÁ¶ÀýÄ¡·á) ÀÌÇýÁ¤(Áß¾ÓÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:30~10:45 Q & A -(-)

ÈÞ½Ä 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 10:45~11:00 Coffee Break -(-)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:00~11:13 (±¸¿¬¹ßÇ¥: A ROOM) Association Between Cortical Thickness and Response to Anti-CGRP Monoclonal Antibodies in Patients with Chronic Migraine Á¶¼öÇö(À»ÁöÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:13~11:26 (±¸¿¬¹ßÇ¥: A ROOM) Is Idiopathic Intracranial Hypertension Really Rare in Asia? A Prospective Multicenter Headache Clinic-based Study about the Frequency of Idiopathic Intracranial Hypertension ±èº´¼ö(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:26~11:39 (±¸¿¬¹ßÇ¥: A ROOM) Effect of Migraine on Suicide Mortality in Young Adults: A Nationwide Cohort Study in South Korea ±è½Â¾Ö(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:39~11:52 (±¸¿¬¹ßÇ¥: A ROOM) Decreased Interictal Serum Butyrate but Unchanged Acetate and Propionate Levels in Individuals with Episodic and Chronic Migraine Á¶¼ö¹Ì(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 11:52~12:05 (±¸¿¬¹ßÇ¥: A ROOM) Clinical Profile and Disease Course of Visual Snow: The First Prospective Asian Cohort with Validation of Diagnostic Criteria À̽ÂÇö(ÀüºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:05~12:18 (±¸¿¬¹ßÇ¥: A ROOM) Efficacy of CGRP Monoclonal Antibodies on Persistent Headaches Following COVID-19 Infection ¼ÛÅÂÁø(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:00~11:13 (±¸¿¬¹ßÇ¥: B ROOM) Eight-teen Years of Triptan Use in Korea: A Nationwide Population-Based Study ÇÏ¿ì¼®(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:13~11:26 (±¸¿¬¹ßÇ¥: B ROOM) Is Tension-type Headache Bilateral? Population Based Subgroup Analysis of Tension-type Headache ÀÌ¿ø¿ì(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:26~11:39 (±¸¿¬¹ßÇ¥: B ROOM) Structural Connectome Alterations in Patients with Episodic Migraine ³ëÀºÂù(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:39~11:52 (±¸¿¬¹ßÇ¥: B ROOM) Exercise As an Abortive Treatment for Cluster Headaches: A Single-center Survey in Korea and A Case Report °­¹Ì°æ(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 11:52~12:05 (±¸¿¬¹ßÇ¥: B ROOM) Rapid Eye Movement Sleep-Dependent Obstructive Sleep Apnea among Patients with mild Obstructive Sleep Apnea and Migraine or Cluster Headache È«À¯È­(ÇѸ²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ½Å¶óȦ 1+2+3 12:05~12:18 (±¸¿¬¹ßÇ¥: B ROOM) Real-world Experience of Lasmiditan for The Acute Treatment of Migraine: A Single Clinic-based Prospective Study Á¤È¸Á¾(¼­¿ïÀÇ´ë)

ÈÞ½Ä 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 12:18~13:10 General Assembly, Award, and Lunch -(-)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:10~13:30 Migraine Precursors and Migraine in Children (¾Æµ¿±â ÆíµÎÅë ¼±ÇàÁõ°ú ÆíµÎÅë) ÀÌÀ±Áø(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:30~13:50 Migraine in Adolescents (û¼Ò³â ½Ã±âÀÇ ÆíµÎÅë) ±ÇÇýÀº(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 13:50~14:10 Migraine in Menopause and Perimenopause (Æó°æ±â¿Í Æó°æÀüÈıâÀÇ ÆíµÎÅë) ±è¼ö°æ(°æ»óÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:10~14:30 Migraine in Older Adults (³ë³â±âÀÇ ÆíµÎÅë) ¼ÛÅÂÁø(ÀÌÈ­ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:30~14:45 Q & A -(-)

ÈÞ½Ä 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 14:45~15:00 Coffee Break -(-)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 15:00~15:30 RCTs and Real World Evidence of Gepants (°ÔÆÇÆ® Ä¡·á) Á¶¼öÇö(À»ÁöÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 15:30~16:00 Good Responders and Non-Responders (CGRPÇ¥ÀûÄ¡·áÀÇ ¹ÝÀÀ ¿¹Ãø) ¹®Èñ¼ö(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 16:00~16:30 Treatment-Related Adverse Events and Management (CGRPÇ¥ÀûÄ¡·áÀÇ ºÎÀÛ¿ë°ú °ü¸®) ¹ÚÁ¤¿í(°¡Å縯ÀÇ´ë)

Åä·Ð 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 16:30~16:40 Q & A -(-)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 16:50~17:30 Nerve Blocks in Headache Disorders (µÎÅëÁúȯ¿¡¼­ ½Å°æÂ÷´Ü¼ú) ¹è´ë¿õ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 23ÀÏ ¼­¿ï µå·¡°ï½ÃƼ È£ÅÚ, ÄÁº¥¼ÇŸ¿ö 3F ±×·£µåº¼·ë ÇѶóȦ 17:30~18:10 Botulinum Toxin Injection in Chronic Migraine (¸¸¼ºÆíµÎÅë¿¡¼­ º¸Åø¸®´®µ¶¼Ò Ä¡·á) ÀÌ¿ø¿ì(¿¬¼¼ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѵÎÅëÇÐȸ 2024³â Ãá°èÇмú´ëȸ : 2024-06-23""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦ 10ȸ ´ëÇÑ»êºÎÀΰúÃÊÀ½ÆÄÇÐȸ ¼­¿ïÁöȸ ¿¬¼ö°­Á : 2024-06-23
´ÙÀ½±Û 2024³â ´ëÇѼÒÈ­±âÇÐȸ ´ë±¸°æºÏÁöȸ ¿¬¼ö°­Á : 2024-06-23
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21030 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (2ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-28 0 5 2024-06-18
21029 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 8 2024-06-18
21028 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 1ÀÏÂ÷ : 2024-06-28 0 11 2024-06-18
21027 ºÎ»ê ´ëÇѽÉÀåÇÐȸ ±âÃÊ°úÇבּ¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö 2024 : 2024-06-28 0 6 2024-06-18
21026 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼҾƳ»ºÐºñÇÐȸ ºñ¸¸¿¬±¸Áý´ãȸ 2024³â 1Â÷ : 2024-06-27 0 8 2024-06-18
21025 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 2 2024-06-18
21024 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 1ÀÏÂ÷ : 2024-06-27 0 6 2024-06-18
21023 ´ë±¸ ´ëÇѹæ»ç¼±Á¾¾çÇÐȸ ´ë±¸°æºÏÁöȸ 3Â÷ Áý´ãȸ : 2024-06-27 0 4 2024-06-18
21022 ¼­¿ï ´ëÇѼҾƸ¶ÃëÇÐȸ ¿Â¶óÀÎ 2024³â Èñ±Í³­Ä¡ Áúȯ ¸¶Ãë ÇÁ·ÎÅäÄÝ ¿þºñ³ª : 2024-06-27 0 6 2024-06-18
21021 ¼­¿ï (1ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-27 0 6 2024-06-18
21020 °­¿ø 2024 ö¿ø±ºÀÇ»çȸ 2Â÷ ¿¬¼ö°­ÁÂ_ÃÖ±Ù ÀÇÇÐÁö°ß(Ä¡¸Å, ¹é³»Àå°ú ³ë¾È) 0 6 2024-06-18
21019 ¼­¿ï Á¦31ȸ ´ëÇѱâÃÊÀÇÇÐ Çмú´ëȸ (1ÀÏÂ÷) - ¿Â/¿ÀÇÁ º´Çà : 2024-06-27 0 5 2024-06-18
21018 ÀüºÏ ±º»ê½ÃÀÇ»çȸ ¿¬¼ö±³À°(±â´É¼º ¼ÒÈ­ºÒ·®Áõ, º¸Çè½É»çÀÇ ÃֽŠÀ̽´) : 2024-06-27 0 4 2024-06-18
21017 ´ë±¸ 2024 ´ëÇÑÀÀ±ÞÀÇÇÐȸ Ãá°èÇмú´ëȸ (1ÀÏÂ÷) : 2024-06-27 0 10 2024-06-18
21016 ºÎ»ê 2024 ±ÝÁ¤±¸ÀÇ»çȸ Çмú´ëȸ(¿¹¹æÁ¢Á¾, ÇʼöÀÇ·áÆÐÅ°Áö) : 2024-06-27 0 9 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷